Press release
Collagen Vascular Diseases Market Share 2021: Global Trends, Key Players, Industry Analysis and Report 2021-2027
The global collagen vascular diseases market is anticipated to grow at a considerable CAGR of around 7.5% during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of collagen vascular diseases such as Scleroderma and arthritis. For instance, according to the Journal of Managed Care and Specialty Pharmacy, the prevalence rates of Scleroderma in the US were 15.1 per 100,000 person-years and 25.9 per 100,000 people respectively. Furthermore, according to the Centers for Disease Control and Prevention, in 2040, an estimated 78.4 million US adults aged 18 years and older will have doctor-diagnosed arthritis among them Two-thirds with arthritis will be women. Also, it is estimated that around 34.6 million adults in the US will report arthritis-attributable activity limitations as well in 2040.A full report of Collagen Vascular Diseases Market is available at: https://www.omrglobal.com/industry-reports/collagen-vascular-diseases-market
Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in December 2019, Pfizer Inc announced that the US Food and Drug Administration (FDA) has approved XELJANZ XR for once-daily treatment of patients with moderate to severely active rheumatoid arthritis those who have an inadequate response to methotrexate. With this approval, Pfizer Inc will be able to offer patients and their healthcare providers with moderate to severely active ulcerative colitis a convenient one daily dosing treatment option with Xeljianz.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/collagen-vascular-diseases-market
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Disease Type
o By Diagnostics
o By Therapeutics
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive AbbVie Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Pfizer Inc, Beckman Coulter, Inc., and Bayer AG, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Collagen Vascular Diseases Market Report Segment
By Disease Type
• Autoimmune Collagen Vascular Diseases
o Lupus
o Rheumatoid Arthritis
o Scleroderma
• Hereditary Collagen Vascular Diseases
By Diagnostics
• Complete Blood Count
• Erythrocyte Sedimentation Rate (ESR)
• C-Reactive Protein
• Rheumatoid Factor
• Others (Urinalysis with Microscopic Analysis & Serum Creatinine)
By Therapeutics
• Corticosteroids
• Immunosuppressive Agents
• Endothelin Receptor Antagonists
• Others (Calcium Channel Blockers, PDE-5 Inhibitors & Chelating Agents)
By End-Users
• Hospital & Clinics
• Diagnostic Centers
• Research Institutes
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/collagen-vascular-diseases-market
Global Collagen Vascular Diseases Market Report Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AbbVie Inc.
• Amgen Inc.
• Bayer AG`
• Bio-Rad Laboratories, Inc.
• Bristol-Myers Squibb Co.
• Cadila Pharmaceuticals Ltd
• Corbus Pharmaceuticals Holdings, Inc.
• Cytori Therapeutics Inc.
• Danaher Corp.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• GenWay Biotech Inc.
• ImmuPharma PLC
• Pfizer Inc.
• Sanofi SA
• Siemens Healthcare AG
• Thermo Fisher Scientific, Inc.
• Svar Life Science AB
• MorphoSys AG
• Merck & Co., Inc.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Collagen Vascular Diseases Market Share 2021: Global Trends, Key Players, Industry Analysis and Report 2021-2027 here
News-ID: 2338578 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
